Bioregenx (BRGX) Free Cash Flow (2022 - 2026)
Bioregenx (BRGX) recorded quarterly Free Cash Flow of $26629.0 in Q1 2026, down 60.0% quarter-over-quarter from $66579.0 in Q4 2025, and down 29.36% on a YoY basis from $37695.0 in Q1 2025.
Bioregenx (BRGX) Free Cash Flow (2022 - 2026) Analysis & Trends
Bioregenx's Free Cash Flow history runs 5 years deep, the most recent figure standing at $26629.0 for Q1 2026.
- In Q1 2026, Free Cash Flow fell 29.36% year-over-year to $26629.0; the TTM figure through Mar 2026 stood at $18849.0 (up 110.35% YoY), while the FY2025 annual figure was $29915.0, up 105.83% from the prior year.
- Free Cash Flow was $26629.0 for Q1 2026 at Bioregenx, down from $66579.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $66579.0 in Q4 2025 to a low of -$649161.0 in Q2 2023.
- Historically, Free Cash Flow has averaged -$119805.2 across 5 years, with a median of -$31196.0 in 2024.
- The sharpest annual moves came in 2023 and 2025: Free Cash Flow sank 5528.46% in 2023, then surged 686.03% in 2025.
- A 5-year view of Free Cash Flow shows it stood at -$4364.0 in 2022, then tumbled by 5528.46% to -$245626.0 in 2023, then jumped by 95.37% to -$11361.0 in 2024, then soared by 686.03% to $66579.0 in 2025, then tumbled by 60.0% to $26629.0 in 2026.
- The last three Free Cash Flow figures came in at $26629.0 (Q1 2026), $66579.0 (Q4 2025), and -$77564.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 1.13 Bn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 119.28 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 81.60 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 43.06 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 26.00 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 107.27 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 69.59 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | -49.47 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 42.07 Mn |
| 10 | Bioregenx | - | - | 348,288.00 | 26,629.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26,629.00 |
| Mar 31, 2026 | 26,629.00 |
| Dec 31, 2025 | 66,579.00 |
| Dec 31, 2025 | 66,579.00 |
| Sep 30, 2025 | -77,564.00 |
| Sep 30, 2025 | -77,564.00 |
| Jun 30, 2025 | 3,205.00 |
| Jun 30, 2025 | 3,205.00 |
| Mar 31, 2025 | 37,695.00 |
| Mar 31, 2025 | 37,695.00 |
| Dec 31, 2024 | -11,361.00 |
| Dec 31, 2024 | -11,361.00 |
| Sep 30, 2024 | -31,196.00 |
| Sep 30, 2024 | -31,196.00 |
| Jun 30, 2024 | -177,341.00 |
| Jun 30, 2024 | -177,341.00 |
| Mar 31, 2024 | -293,640.00 |
| Mar 31, 2024 | -293,640.00 |
| Dec 31, 2023 | -245,626.00 |
| Dec 31, 2023 | -245,626.00 |